–
Gain Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.8
FY22:
−17.8
FY23:
−22.3
FY24:
−20.4
FY25:
−18.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.7
FY22:
−17.6
FY23:
−21.7
FY24:
−20.4
FY25:
−17.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.9
FY22:
−17.5
FY23:
−22.2
FY24:
−19.9
FY25:
−19.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.9
FY22:
−17.6
FY23:
−22.3
FY24:
−20.4
FY25:
−20.2
All amounts in millions USD